EP1605895A4 - ORAL INSULIN THERAPY AND PROTOCOL - Google Patents
ORAL INSULIN THERAPY AND PROTOCOLInfo
- Publication number
- EP1605895A4 EP1605895A4 EP04718148A EP04718148A EP1605895A4 EP 1605895 A4 EP1605895 A4 EP 1605895A4 EP 04718148 A EP04718148 A EP 04718148A EP 04718148 A EP04718148 A EP 04718148A EP 1605895 A4 EP1605895 A4 EP 1605895A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- protocol
- oral insulin
- insulin therapies
- therapies
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US448465P | 2003-02-21 | ||
US45266003P | 2003-03-06 | 2003-03-06 | |
US452660P | 2003-03-06 | ||
US48846503P | 2003-07-17 | 2003-07-17 | |
US49729603P | 2003-08-22 | 2003-08-22 | |
US497296P | 2003-08-22 | ||
US51816803P | 2003-11-07 | 2003-11-07 | |
US518168P | 2003-11-07 | ||
US53509104P | 2004-01-07 | 2004-01-07 | |
US535091P | 2004-01-07 | ||
US54046204P | 2004-01-29 | 2004-01-29 | |
US540462P | 2004-01-29 | ||
PCT/US2004/006943 WO2004080401A2 (en) | 2003-03-06 | 2004-03-05 | Oral insulin therapies and protocol |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1605895A2 EP1605895A2 (en) | 2005-12-21 |
EP1605895A4 true EP1605895A4 (en) | 2011-08-24 |
Family
ID=35457030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04718148A Withdrawn EP1605895A4 (en) | 2003-03-06 | 2004-03-05 | ORAL INSULIN THERAPY AND PROTOCOL |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1605895A4 (ja) |
JP (1) | JP5658619B2 (ja) |
AU (1) | AU2004220544B2 (ja) |
CA (1) | CA2518216C (ja) |
WO (1) | WO2004080401A2 (ja) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
WO2005072803A1 (en) | 2004-01-16 | 2005-08-11 | Biodel, Inc. | Sublingual drug delivery device |
US20080090753A1 (en) | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
EP2279732B1 (en) | 2004-05-14 | 2019-03-20 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
EP1750718B1 (en) | 2004-05-19 | 2014-08-13 | Emisphere Technologies, Inc. | Acyclovir formulations |
EP1786784B1 (en) | 2004-08-20 | 2010-10-27 | MannKind Corporation | Catalysis of diketopiperazine synthesis |
CA2578175C (en) | 2004-08-23 | 2014-10-14 | Mannkind Corporation | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
ES2535311T3 (es) | 2004-12-29 | 2015-05-08 | Emisphere Technologies, Inc. | Formulaciones farmacéuticas de sales de galio |
US8110547B2 (en) | 2005-01-12 | 2012-02-07 | Emisphere Technologies, Inc. | Compositions for buccal delivery of parathyroid hormone |
WO2006084164A2 (en) | 2005-02-01 | 2006-08-10 | Emisphere Technologies, Inc. | Gastric retention and controlled release delivery system |
WO2007016600A2 (en) * | 2005-08-01 | 2007-02-08 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
US7803404B2 (en) | 2005-09-14 | 2010-09-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
WO2007121318A2 (en) * | 2006-04-12 | 2007-10-25 | Emisphere Technologies, Inc. | Formulations for delivering insulin |
WO2007133944A2 (en) | 2006-05-09 | 2007-11-22 | Emisphere Technologies, Inc. | Topical administration of acyclovir |
CA2656019C (en) | 2006-06-28 | 2016-09-13 | Emisphere Technologies, Inc. | Gallium nitrate formulations |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
EP2570147B1 (en) | 2008-06-13 | 2017-10-18 | MannKind Corporation | A dry powder inhaler and system for drug delivery |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9060927B2 (en) | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
KR20180079458A (ko) | 2009-06-12 | 2018-07-10 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
EP2461803B1 (en) | 2009-08-03 | 2018-10-17 | Emisphere Technologies, Inc. | Fast-acting naproxen composition with reduced gastrointestinal effects |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
CN105667994B (zh) | 2011-04-01 | 2018-04-06 | 曼金德公司 | 用于药物药盒的泡罩包装 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain |
CN108057154B (zh) | 2012-07-12 | 2021-04-16 | 曼金德公司 | 干粉药物输送系统和方法 |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
EP2939024B1 (en) | 2012-12-26 | 2021-04-28 | Quest Diagnostics Investments Incorporated | C peptide detection by mass spectrometry |
CA2906817C (en) | 2013-03-15 | 2022-01-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
JP2016530930A (ja) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | 通気装置及び方法 |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US20210220443A1 (en) * | 2018-06-18 | 2021-07-22 | Biocon Limited | Method and use of controlling postprandial glucose levels in a subject |
CN113473911A (zh) | 2018-12-28 | 2021-10-01 | 德克斯康公司 | 血糖功能障碍的评估和可视化 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002002509A1 (en) * | 2000-06-29 | 2002-01-10 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO2003057170A2 (en) * | 2002-01-07 | 2003-07-17 | Emisphere Technologies, Inc. | Oral insulin therapy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5665389A (en) * | 1995-05-24 | 1997-09-09 | University Of Maryland At Baltimore | Oral dosage composition for intestinal delivery and method of treating diabetes |
JP2002543092A (ja) * | 1999-04-27 | 2002-12-17 | イーライ・リリー・アンド・カンパニー | 肺投与用インスリン結晶 |
US7060675B2 (en) * | 2001-02-15 | 2006-06-13 | Nobex Corporation | Methods of treating diabetes mellitus |
US7137951B2 (en) * | 2002-10-23 | 2006-11-21 | Joseph Pilarski | Method of food and insulin dose management for a diabetic subject |
ES2465496T3 (es) * | 2003-01-06 | 2014-06-05 | Emisphere Technologies, Inc. | Terapia de insulina oral nocturna |
-
2004
- 2004-03-05 AU AU2004220544A patent/AU2004220544B2/en not_active Ceased
- 2004-03-05 WO PCT/US2004/006943 patent/WO2004080401A2/en active Search and Examination
- 2004-03-05 CA CA2518216A patent/CA2518216C/en not_active Expired - Fee Related
- 2004-03-05 EP EP04718148A patent/EP1605895A4/en not_active Withdrawn
-
2011
- 2011-05-19 JP JP2011112583A patent/JP5658619B2/ja not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002002509A1 (en) * | 2000-06-29 | 2002-01-10 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO2003057170A2 (en) * | 2002-01-07 | 2003-07-17 | Emisphere Technologies, Inc. | Oral insulin therapy |
Also Published As
Publication number | Publication date |
---|---|
CA2518216C (en) | 2017-05-09 |
EP1605895A2 (en) | 2005-12-21 |
AU2004220544A1 (en) | 2004-09-23 |
AU2004220544B2 (en) | 2010-06-17 |
CA2518216A1 (en) | 2004-09-23 |
JP5658619B2 (ja) | 2015-01-28 |
WO2004080401A3 (en) | 2006-01-12 |
JP2011162560A (ja) | 2011-08-25 |
WO2004080401A2 (en) | 2004-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1605895A4 (en) | ORAL INSULIN THERAPY AND PROTOCOL | |
HK1253918A1 (zh) | 可吸入腎上腺素 | |
EP1469812A4 (en) | ORAL INSULIN THERAPY | |
EP1648327A4 (en) | ORAL DEVICES AND METHODS OF CONTROLLED MEDICAMENT DELIVERY | |
AU2003904278A0 (en) | Improved oral oxygenating device | |
EP1539129A4 (en) | DOSAGE FORMS AND RELEVANT THERAPIES | |
IL176248A0 (en) | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof | |
HK1085131A1 (en) | Solid drug for oral use | |
HK1085133A1 (en) | Night-time oral insulin therapy | |
AU2003268419A1 (en) | Combined toothbrush and flossing device | |
EP1619193A4 (en) | SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF | |
EP1661594A4 (en) | SYRINGE | |
AU2003259457A8 (en) | Auto-destructible syringe | |
EP1620066A4 (en) | ORAL CARE PROCESSES AND PRODUCTS | |
GB0308382D0 (en) | Therapeutic methods and means | |
AP2006003666A0 (en) | Syringe | |
GB2401043B (en) | Drug | |
GB0222090D0 (en) | Dental methods | |
AU2003277757A1 (en) | Dental handpiece | |
EP1653953A4 (en) | METHOD AND DEVICES FOR THE MEDICINAL PRODUCTION | |
EP1624073A4 (en) | DRUG | |
AU2003906273A0 (en) | Oral insert/sleep monitor/communication device | |
GB0327913D0 (en) | Medicament | |
GB0327912D0 (en) | Medicament | |
GB0301842D0 (en) | Medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20051006 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
R17D | Deferred search report published (corrected) |
Effective date: 20060112 |
|
R17D | Deferred search report published (corrected) |
Effective date: 20060223 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1087012 Country of ref document: HK |
|
R17D | Deferred search report published (corrected) |
Effective date: 20060112 |
|
R17D | Deferred search report published (corrected) |
Effective date: 20060223 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20110725 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/20 20060101ALI20110719BHEP Ipc: A61K 9/48 20060101ALI20110719BHEP Ipc: A61K 38/28 20060101AFI20110719BHEP |
|
17Q | First examination report despatched |
Effective date: 20130117 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1087012 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20221001 |